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B cells develop in the BM and fetal liver, gener-
ating antigen receptors with random combina-
tions of heavy and light chains. As a consequence, 
many BCRs initially have affinity for self- 
tissues. Cells carrying autoreactive receptors are 
regulated by mechanisms including apoptosis, 
induction of anergy, or receptor editing. Re-
ceptor editing was first described as a process of 
secondary light chain gene rearrangement in 
immature autoreactive B cells of the BM re-
sulting in the rescue of cells with reduced auto-
reactivity (Gay et al., 1993; Tiegs et al., 1993). 
Experiments in mice and humans showed that 
20–50% of all developing B cells undergo edit-
ing (Harada and Yamagishi, 1991; Prak and   
Weigert,  1995;  Retter  and  Nemazee,  1998; 
Bräuninger et al., 2001; Casellas et al., 2001; 
Oberdoerffer et al., 2003; Halverson et al., 2004; 
Wardemann et al., 2004). However, not all auto-
antigens are present in the BM and fetal liver. 
Many B cells confront self-antigens in the pe-
riphery and must be regulated by tolerance at 
later  stages  of  development.  B  cell  tolerance 
against specific tissue antigens was shown using 
several models, but the results varied from dele-
tion to anergy to clonal ignorance (Russell   
et al., 1991; Akkaraju et al., 1997; Lang et al., 
1997; Rojas et al., 2001). Even after these selec-
tions, a significant fraction (5–20%) of mature 
naive B cells are reported to retain self-reactivity 
(Dighiero et al., 1983; Rolink et al., 1987; 
Souroujon et al., 1988; Guigou et al., 1991; 
Hayakawa et al., 1999; Wardemann et al., 2003). 
Tolerance triggered by autoantigen has also 
been proposed to promote editing at even later 
CORRESPONDENCE  
David Nemazee: 
nemazee@scripps.edu
Abbreviations used: ALT,  
alanine transaminase; BAFF,  
B cell–activating factor belonging 
to the tumor necrosis factor 
family; HEL, hen egg lysozyme; 
i, intracellular ; mRNA, 
messenger RNA; MZ, marginal 
zone; sIg, surface Ig.
Liver-expressed Ig superantigen induces 
tolerance of polyclonal B cells by clonal 
deletion not  to  receptor editing
Takayuki Ota,1 Miyo Ota,1 Bao Hoa Duong,1,2 Amanda L. Gavin,3  
and David Nemazee1
1Department of Immunology and Microbial Science and 2Kellogg School of Science and Technology Doctoral Program  
in Chemical and Biological Sciences, The Scripps Research Institute, La Jolla, CA 92037
3Burnet Institute, Melbourne, Victoria, Australia 3004
Little is know about the nature of peripheral B cell tolerance or how it may vary in distinct 
lineages. Although autoantibody transgenic studies indicate that anergy and apoptosis are 
involved, some studies claim that receptor editing occurs. To model peripheral B cell toler-
ance in a normal, polyclonal immune system, we generated transgenic mice expressing an 
Ig–light chain–reactive superantigen targeted to the plasma membrane of hepatocytes 
(pAlb mice). In contrast to mice expressing  superantigen ubiquitously, in which  cells 
edit efficiently to , in pAlb mice,  B cells underwent clonal deletion. Their  cells failed 
to populate lymph nodes, and the remaining splenic  cells were anergic, arrested at a 
semi-mature stage without undergoing receptor editing. In the liver,  cells recognized 
superantigen, down-regulated surface Ig, and expressed active caspase 3, suggesting ongo-
ing apoptosis at the site of B cell receptor ligand expression. Some, apparently mature,  
 B1 and follicular B cells persisted in the peritoneum. BAFF (B cell–activating factor 
belonging to the tumor necrosis factor family) overexpression rescued splenic  B cell 
maturation and allowed  cells to populate lymph nodes. Our model facilitates analysis of 
tissue-specific autoimmunity, tolerance, and apoptosis in a polyclonal B cell population.  
The results suggest that deletion, not editing, is the major irreversible pathway of tolerance 
induction among peripheral B cells.
© 2011 Ota et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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Lang et al., 1997; Kench et al., 1998; Kouskoff et al., 2000). 
However, in a high affinity anti–hen egg lysozyme (HEL) 
transgenic mouse crossed to a thyroid-specific membrane HEL 
strain, autoreactive B cells were functional, and Ig deposition 
was observed in the thyroid (Akkaraju et al., 1997). The rea-
sons for the differences in the fates of the autoreactive B cells 
in the two models has not been completely defined but is 
presumably explained by differences in antigen accessibility to 
B cells, rather than BCR affinity for autoantigen, because the 
affinity of the 3-83 BCR for Kb is only 3 × 105 M1, 
whereas the HEL antibody affinity is 1,000-fold tighter.  An 
additional complication in these studies was that they used 
conventional Ig transgenic mice, which cannot undergo re-
ceptor editing efficiently.
To clarify the fate of autoreactive B cells in an indepen-
dent way that is less likely to bias results than those based on 
BCR transgenic mice, we developed a mouse expressing a 
 superantigen restricted to liver tissue. This approach takes 
advantage of a custom superantigen technology in which a 
membrane-tethered  single-chain  antibody  reactive  to  Ig 
(called -macroself antigen) is expressed on host cells (Aït-
Azzouzene et al., 2005). The strategy avoids manipulation of 
B cells in any way but permits analysis of their responses to 
tolerogen in a polyclonal immune system. The goal was to as-
sess the ability of an Ig-reactive macroself antigen expressed 
specifically on liver cells to promote B cell tolerance, with a 
view to establishing a general model for tolerance to tissue-
specific antigen that is useful for screens of mutations affect-
ing this process. As a proof of principle, we show that BAFF 
overexpression can abrogate peripheral tolerance in this sys-
tem and that T cells do not facilitate tolerance.
RESULTS
Development of liver-specific -macroself transgenic mice
A liver-directed -macroself transgene (pAlb) was generated 
by expressing the  superantigen protein–coding elements, 
described  previously  for  a  ubiquitously  expressed  version 
(pUIi; Aït-Azzouzene et al., 2005), under the control of the 
albumin promoter and both albumin and -fetoprotein en-
hancers. This  design  has  been  successfully  used  to  make 
liver-specific cre-expressing mice (Postic et al., 1999). pAlb 
transgenic mice were generated by microinjection of C57BL/6 
(B6) zygotes. We generated 26 founder mice carrying the 
transgene. Four founders that had to varying extents reduced 
serum  concentration were initially selected for more de-
tailed study. The data presented in this study come from one 
typical line of mice derived from founder #26. First, we eval-
uated the tissue specificity of gene expression by quantitative 
RT-PCR. As shown in Fig. 1 A, -macroself messenger RNA 
(mRNA) expression was extremely specific to the liver, al-
though we detected weak gene expression in the lung and 
intestine (<0.1% as much). Next, superantigen protein ex-
pression  was  measured  using  antibody  to  the  -macroself 
protein. As  predicted  based  on  RNA  expression,  pAlb 
splenocytes lacked detectable staining above the background 
defined in splenocytes from WT mice (Fig. 1 B, blue lines). 
developmental  stages  (Sandel  and  Monroe,  1999;  Hippen   
et al., 2005; Rice et al., 2005), although the extent to which 
tolerance is responsible for RAG-mediated recombination in 
the peripheral B cells and the state of maturity of these cells 
are controversial (Nemazee and Weigert, 2000).
B cells released from the BM complete their maturation 
through several transitional stages that have been best charac-
terized in the spleen. T1, T2, and T3 transitional B cells are 
defined by cell surface phenotype and functional characteris-
tics (Allman et al., 2001; Chung et al., 2002; Su and Rawlings, 
2002). In the mouse, all transitional B cell subsets express 
CD93, and BrdU labeling studies indicate that they turn over 
relatively rapidly (Allman et al., 1993; Rolink et al., 1998).   
It has been suggested that clonal deletion of autoreactive cells 
might take place among transitional cells (Carsetti et al., 1995; 
Allman et al., 2001; Merrell et al., 2006; Duong et al., 2010).   
T1 cells are the least mature; upon BCR stimulation in vitro, 
T1 cells fail to proliferate and are induced to apoptosis. T2 cells 
appear to be more responsive to stimuli, including BCR   
ligands and the cytokine BAFF (B cell–activating factor be-
longing to the tumor necrosis factor family), and they can 
mature into B2 and marginal zone (MZ) subsets. Other sub-
sets  of  immature  B  cells  include  T3  cells,  which  are 
IgMloCD23+CD93+ (Allman et al., 2001), and the recently 
defined IgMloCD23loCD93+ T3 (T3-like) population. De-
tailed analyses using BCR transgenic mouse models suggested 
that the T3 subset contains many anergic cells whose pheno-
type is maintained by continuous antigen stimulation through 
the BCR (Merrell et al., 2006). T3 phenotype cells are few in 
number in WT mice, but are abundant in the 3H9-56R/V8 
double-stranded DNA–specific BCR transgenic model (Kiefer 
et al., 2008). T3 and T3 populations have been shown to un-
dergo  secondary  light  chain  rearrangement  (Kiefer  et  al., 
2008); however, the data were obtained from BCR transgenic 
rather than WT mice.
BAFF  (TNFSF13B)  is  essential  for  follicular  and  MZ   
B  cell  survival  and  development  (Mackay  and  Schneider, 
2009). The soluble form binds to three receptors, BAFF-R, 
TACI, and BCMA. BAFF-R is most highly expressed on ma-
ture B cells. Null mutants of BAFF or BAFF-R show a block 
of B cell development at the T2 stage. In contrast, the over-
expression of BAFF causes increased B cell number and ele-
vated serum Ig and induces a systemic lupus erythematosus–like 
disease. The serum level of BAFF is elevated in systemic lupus 
erythematosus and Sjögren’s syndrome patients (Mackay et al., 
1999; Cheema et al., 2001; Zhang et al., 2001; Groom et al., 
2002). Excess BAFF can promote the survival of autoreactive 
B cells (Lesley et al., 2004; Thien et al., 2004; Ota et al., 2010), 
but it is not known how BAFF affects tissue-specific autore-
active B cells.
B cell peripheral tolerance to tissue-restricted membrane 
antigen was previously studied mainly with two BCR trans-
genic mouse models. In the 3-83 model, liver-specific expres-
sion of a weakly bound autoantigen, MHC class I Kb, led to 
significant reductions in B cell numbers in the spleen and their 
almost total elimination in lymph nodes (Russell et al., 1991; JEM VOL. 208, March 14, 2011 
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the massive (approximately sevenfold) 
increase in recirculating  cells charac-
teristic of pUIi mice (Fig. 2, B, G, and 
H;  Aït-Azzouzene  et  al.,  2005).  In 
peritoneum,  B cell frequencies in pAlb mice were reduced 
by 90% (Fig. 2 I). As B1 cells are positively selected by some 
autoantigens (Hayakawa et al., 1999) and are generally resis-
tant to cell death (Otero et al., 2006), we expected most of the 
remaining  B cells in pAlb peritonea to be B1 B cells. Sur-
prisingly however, they were comprised of similar proportions 
of B1 (CD19hiB220lo) and B2 (CD19+B220hi) B cells (Fig. 2 J). 
Serum IgG and IgM levels in pAlb mice were reduced com-
pared with WT by 58% and 67%, respectively (IgG, 1,628 ± 
296 µg/ml vs. 3,919 ± 1,169 µg/ml; IgM, 11.1 ± 1.10 µg/ml 
vs. 33.7 ± 9.3 µg/ml; pAlb, n = 14; WT, n = 11). Overall, the 
phenotype of pAlb mice was consistent with deletion of   
 B cells at a late stage in B cell development outside of the 
BM, with a residual peritoneal  population that was resistant 
to, or had possibly failed to encounter, autoantigen.
 B cells in pAlb mice are immature and anergic
We further characterized the maturation state and func-
tionality of  B cells in the spleens of pAlb mice to deter-
mine whether they might be anergic or simply immature. 
Gating on + cells revealed a lack of MZ and follicular cells 
and few CD93 B cells, whereas gating on splenic +  
B cells showed a typical B cell profile, although with a higher 
proportion of MZ B cells (Fig. 2, E and F). In pAlb spleens, 
+ cells had significantly lower IgD expression and slightly 
lower IgM expression than controls (Fig. 3, A–C). This re-
duced  BCR  density  was  also  seen  in  comparison  with 
CD93+ B cells of WT mice (Fig. 3 B). Moreover, most +  
B cells in pAlb spleens had the CD23loIgMloIgD+CD93hi T3 
phenotype (Fig. 3 C). These cells also had high levels of 
CD24  (heat-stable  antigen),  which  is  characteristic  of 
newly formed B cells (Fig. 3 B). The reduced surface Ig 
(sIg) levels and up-regulated MHCII levels were consistent 
As a positive control, we show the superantigen expression on 
pUIi splenocytes (Fig. 1 B, red lines). We confirmed that 
there was a high level of protein expression in liver by staining 
frozen sections (Fig. 1 C). The results thus show liver-specific 
superantigen expression in pAlb mice.
Because Ig was absent from the sera of pAlb mice (<0.1 
µg/ml; see Fig. 4 C, NL), we assessed using flow cytometry 
the changes in phenotypes and numbers of  B cells in lym-
phoid tissues. As shown in Fig. 2, in pAlb mice, the numbers 
of B cells expressing  were reduced by 80–90% in spleen 
(Fig. 2, A and C) and by >99% in lymph nodes (Fig. 2,   
A and D). In contrast, those expressing  were barely affected, 
with a 50% numerical increase compared with WT in spleen 
(Fig. 2, B and C) and no significant difference in lymph nodes 
(Fig. 2 D). The increase of  cells specifically in the spleens of 
pAlb mice could be explained by homeostasis of the MZ   
B cell compartment, as its size was normal in pAlb mice but 
now made up exclusively of  cells, representing a ninefold 
increase of  MZ B cells over WT (Fig. 2, E and F; note  MZ 
identified here as , B220+CD23loCD21hi). The remaining 
 B cells found in pAlb spleens had a distinctly lower level of 
B220 compared with -negative B cells (Fig. 2 A), whereas   
 cells were similar in phenotype to those of WT mice. In BM, 
pAlb mice lacked the B220hi+ recirculating cell population 
(Fig. 2, A and H), but other compartments were normal, 
including all compartments of  cells (Fig. 2, B, G, and H), 
indicating that the perturbations caused by superantigen 
expression were restricted to late stages of  B cell matura-
tion. For comparison, we show the analysis of  and  cells in 
pUIi mice, in which B cells encounter superantigen in the BM 
and undergo central tolerance with receptor editing (Fig. 2, A 
and B). In contrast to pUIi mice, the BM of pAlb mice lacked 
a significant increase in newly formed, B220int  BM cells or 
Figure 1.  Liver-specific expression of 
pAlb  superantigen transgene. RNA and 
protein expression analysis of  superantigen 
gene expression in pAlb transgenic mouse line 
#26. (A) RNA was purified from the indicated 
tissues, and  superantigen gene expression 
was determined by quantitative PCR. Shown 
are mean and SEM from three different mice. 
(B) Superantigen expression on splenocytes 
identified with anti–rat IgG and gated for 
expression of CD3 or B220. WT (gray histo-
gram), pAlb (blue line), and pUIi (red line; 
positive control) are shown. Similar results 
were obtained in five independent experi-
ments. (C) Liver frozen sections from WT or 
pAlb mice were stained with FITC anti–Rat 
IgG1 and enhanced with Alexa Fluor 488 anti-
FITC, and results were similar in three inde-
pendent pairs of WT and pAlb mice.620 Peripheral tolerance by deletion | Ota et al.
Figure 2.  Reduced numbers of  B cells in pAlb spleen, lymph node, and peritoneum. The indicated tissues from WT, pAlb, or pUIi mice were ana-
lyzed by flow cytometry using the indicated antibody combinations. Plots shown were gated on CD4CD8 lymphocytes. (A and B) Flow cytometric analysis 
of  (A) and  (B) B cells in BM, spleen, and lymph nodes of pAlb mice. Top panels indicate with bottom and top boxes B220intsIg+ immature B cells and 
B220hisIg+ recirculating B cells, respectively. (C and D) Statistical analysis of absolute  and  B cell numbers in spleen (C) and lymph nodes (D) from five  
WT and seven pAlb mice. (E and F) MZ B cell analysis. E shows analysis scheme defining  MZ B cells among B220+ cells along with summary data in F. 
(G and H) Analysis of BM immature and recirculating B cell numbers in gates defined in A and B from three WT, three pAlb, and three pUIi mice. (I and J) +  
B cells in peritoneum (I) were further analyzed for CD19 and B220 expression levels (J). Boxes indicating CD19+B220int (left) and CD19+B220hi (right) identify 
B1 and B2 B cells, respectively. Results were derived from at least three independent experiments except for the data from pUIi mice, which were obtained 
in one experiment. Shown are means and SEM. *, P < 0.05; **, P < 0.005; ***, P < 0.0005; ns, not significant (two-tailed t test).JEM VOL. 208, March 14, 2011 
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Figure 3.  Anergy and apoptosis but no receptor editing in pAlb  B cells. (A–J) Analysis in pAlb and WT mice of sIg levels, maturation markers, Ca2+ 
response, and RAG expression, among spleen cells (A–F) and analysis of sIg L-chains and apoptosis in liver B cells (G–J). (A) IgD and IgM expression level in 
B220+ B cells. (B) Cell surface markers of B220+ gated splenocytes. pAlb (red line), WT (blue line), CD93+ (black line), and negative control (gray area) are 
shown. HSA, heat-stable antigen. (C) Transitional cells, identified as B220+CD93+, are defined as T1-T3 and T3 subfractions in the quadrants of the rightmost 
plots as follows: T1, IgM+CD23; T2, IgM+CD23+; T3, IgMloCD23+; and T3, IgMloCD23. (D) Spleen cells of the indicated genotypes were loaded with Indo-1, 
gated on CD4CD8Gr-1 lymphocytes, and stimulated with anti- at a final concentration of 2 µg/ml. Indo-1 405/485-nm emission ratio fluorescence 
data were acquired at room temperature for 200 s. (E) Analysis of  and  expression on B220-gated pAlb or WT spleen cells. (F) Analysis of Rag1 and Rag2 
expression by quantitative PCR. WT BM fraction was sorted with B220 microbeads (MACS), and  splenocytes of the indicated mice were purified using bioti-
nylated anti- followed by antibiotin microbeads. Data in A–C and E are representative of five mice/group; data in D are representative of three mice/group.  
F shows means and SEM of three mice/group. (G–J) Lymphocytes from mice of the indicated genotypes were isolated over density gradients from perfused 
livers and stained with the indicated antibodies. The gray area in J shows the level of staining on T cells. Data are representative of four mice/group.
with previous antigen encounter (Cambier et al., 2007), as 
was the reduction in CD19 expression (Fig. 3 B). In re-
sponse to BCR ligation, these cells mobilized Ca2+ poorly 
upon stimulation with anti- (Fig. 3 D) or anti-IgM (Fig. S1 A; 
however, we were unable to detect any elevation in basal 
Ca2+ levels in Fig. S1 B). Moreover, BrdU labeling experi-
ments indicated that these cells turned over rapidly (Fig. S1 C). 
These data indicated that  B cells in spleens of pAlb mice 
were mainly recently formed and autoantigen-experienced 
anergic cells.622 Peripheral tolerance by deletion | Ota et al.
splenocytes, whereas Rag2 mRNA was 
slightly elevated, and both were far 
lower than that found in BM B cells (Fig. 3 F; note log scale). 
We conclude that receptor editing in pAlb spleen cells was 
insignificant or absent and that  autoreactive B cells were 
mainly or exclusively tolerized by clonal elimination.
sIg down-regulation and apoptosis in the liver
To assess the phenotype of B cells at the site of superantigen 
expression,  tissue-associated  lymphocytes  were  isolated  from   
livers of pAlb or control mice after perfusion to remove blood 
cells. In pAlb mice, liver B cells had no detectable sIg (Fig. 3 H),   
but many scored positive for intracellular  (i; Fig. 3 I), indi-
cating that they had down-regulated their receptors. These 
cells had a distinctly reduced level of B220 and CD19 com-
pared with  cells present in the same tissue, reminiscent of 
the pattern in spleen (Fig. 3, G, I, and J). Interestingly, a signifi-
cant subset of CD19+ B cells in pAlb livers was positive for 
active caspase 3 (Fig. 3 G; 1.6 ± 0.2% in pAlb vs. 0.08 ± 
0.01% in WT; P < 0.0001), suggesting that at any given time 
3–4% of  B cells in livers of pAlb mice 
had initiated an apoptotic pathway after sIg 
engagement by superantigen. We were unable 
No obvious editing of  B cells to 
As the extent to which peripheral B cells might undergo re-
ceptor editing in response to an encounter with autoantigen 
is unclear, we assessed this by measuring RAG mRNA levels 
and by looking for evidence of editing at the level of light 
chain protein expression. We considered the possibility that, in 
the pAlb model,  B cell survival might require editing in the 
periphery to  or perhaps the coexpression of  chain along 
with . However, we obtained little evidence supporting this 
idea. Compared with WT mice, the absolute number of   
B cells in pAlb mice was only slightly increased in spleens and 
not at all in lymph nodes (Fig. 2, C and D), and we failed to 
detect any increase in the proportion of /–double positive 
cells (Fig. 3 E). (As noted previously, in mice expressing the 
-macroself antigen ubiquitously, which induces significant 
editing,  B cell numbers are elevated by sevenfold [Aït- 
Azzouzene et al., 2005].) In sorted pAlb + B cells, Rag1 
mRNA expression levels were equivalent to those of WT 
Figure 4.  Maternal Ig affects peripheral 
tolerance in pAlb mice. pAlb male mice 
were crossed to WT female mice, and pups 
were analyzed. Based on the frequency of  
+ B cells in the peripheral blood, mice were 
separated into two groups, nonleaky (NL) and 
leaky (L). (A) Representative  and  staining 
is shown for spleen and lymph nodes. (B)  
and  B cell numbers in spleen. Shown are 
means and SEM of three nonleaky and five 
leaky mice. (C) Serum Ig concentration 
(conc) from mice of the indicated types was 
measured by ELISA. Each point represents the 
value obtained from an individual mouse (NL, 
n = 6; L, n = 9; WT, n = 10). Horizontal lines 
represent means of the individual values.  
(D) Comparison of the transgene mRNA ex-
pression levels in the liver of the indicated 
mice as measured by quantitative PCR. Shown 
are the mean and SEM of three nonleaky and 
five leaky mice. **, P < 0.005; ***, P < 0.0005 
(two-tailed t test).
Figure 5.  No T cell requirement for peripheral  
B cell tolerance in pAlb mice. pAlb male mice were 
bred to TCR-// mice to generate TCR-// 
pAlb mice (TCR/ pAlb mice), and B cell deletion was 
analyzed by flow cytometry. (A) Representative analy-
sis of  B cells in spleen and lymph nodes. (B) CD93 
expression in + cells in spleen. TCR/ pAlb (black 
line) and TCR/ (gray area) are shown. (C) Shown is 
the statistical analysis of the total  and  cell num-
bers in TCR+/ and TCR/ pAlb mice. Means and SEM 
of three TCR+/ pAlb and four TCR/ pAlb mice are 
shown. *, P < 0.05 (two-tailed t test).JEM VOL. 208, March 14, 2011 
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We  conclude  that  maternal  IgGs 
probably masked the binding site of 
superantigen and impaired tolerance 
induction in a subset of mice and that 
this effect did not occur in transgenic 
offspring of pAlb mothers because of 
their low serum Ig levels.
No requirement for T cells  
in peripheral deletion of  B cells
Because some autoreactive B cells 
have been shown to be killed by 
CD4 T cells through Fas signaling 
(Rathmell et al., 1995), we assessed   
B cell deletion in pAlb mice lacking all 
T cells (TCR/ pAlb) generated 
by  introducing  null  mutations  of 
TCR- and  TCR- (TCR-//;   
Mombaerts et al., 1992, 1994). As in TCR-sufficient pAlb 
mice,  cells in TCR/ pAlb mice were efficiently deleted 
(Fig. 5 A), and the remaining  splenocytes in these mice ex-
pressed higher levels of CD93 when compared with TCR/ 
control mice lacking superantigen (Fig. 5 B). The absolute 
numbers of  B cells in TCR/ pAlb spleens were almost 
the same as in TCR+/ pAlb mice, but  cells were increased 
by 30% (Fig. 5 C). No other obvious differences between T 
cell–sufficient and –deficient pAlb mice were seen. In  TCR/ 
pAlb mice, interestingly, pups from female TCR-// mice 
crossed to male pAlb TCR-// mice lacked  B cell 
escape as described in Fig. 4 for T cell–sufficient mice, proba-
bly because of their lower maternal IgG levels. In any case, 
these data exclude a role for T cells in the B cell deletion in 
pAlb mice.
BAFF overexpression allows  B cell escape in the periphery
We next investigated the effects of BAFF overexpression in 
the pAlb model because of the correlations between elevated 
to detect a difference in active caspase 3 in the spleens of pAlb 
mice, presumably because such cells were rapidly phagocy-
tosed or because the rate of apoptosis was lower.
Maternal IgG affects the efficiency of peripheral tolerance
Because maternally derived IgG/ Igs transported to the 
fetus might mask the  superantigen expressed in the liver, 
diminishing tolerance induction, in most experiments, we avoided 
this by crossing the female pAlb transgenics to male B6 WT 
mice. However, to assess the potential effect of maternal IgGs, 
we tested offspring of male pAlb bred to B6 females. In these 
(WT × pAlb)F1 pups, 7 out of 13 (54%) had more  B cells 
in the periphery (Fig. 4, A and B) than did (pAlb × WT)F1 
mice. In the subset with higher levels of  cells,  B cells were 
detected in lymph nodes, and serum Ig was detected, albeit 
at significantly lower levels than in WT mice (Fig. 4 C; indi-
cated in the figure as “leaky” [L], as opposed to “nonleaky” [NL], 
i.e., mice with low  B cell levels). Leaky and nonleaky mice did 
not differ in their superantigen mRNA expression (Fig. 4 D). 
Figure 6.  Overexpression of BAFF  
allows  B cell escape from tolerance. 
Analysis of peripheral B cell tolerance in pAlb/
BAFF double transgenic mice. (A–D) Flow 
cytometry analysis of  B cell numbers in 
spleen and lymph node cells. For i staining 
(D), surface  was blocked by unlabeled 
antibody (187.1) before fixation and per-
meabilization. (B and C) Horizontal lines 
represent means of the individual values.  
(E) CD138 and CD19 expression on B220loi+ 
gated cells (red line, B220loi+; black line, 
B220+; gray area, TCR-+). (F) Ca response 
in + B cells from mice of the indicated 
genotypes. Cells were gated to CD4, CD8, 
Gr-1, -negative population (gray area, WT). 
Data were obtained from the following 
numbers of mice/group: n = 6 WT, n = 5 
pAlb, n = 10 BAFF, and n = 8 pAlb/BAFF.624 Peripheral tolerance by deletion | Ota et al.
(Fig. 7 A, bottom). Interestingly, we failed to see an increase of 
alanine transaminase (ALT) in the sera of either strain (Fig. 7 B), 
suggesting  minor  tissue  damage  and  inflammation  despite 
lymphocytic infiltration and autoantibody production.
DISCUSSION
Our findings support the notion that self-ligands expressed 
on hepatocytes promote peripheral clonal deletion of autore-
active B cells with little or no induction of receptor editing.   
 B cells of pAlb mice were reduced in number in the spleen 
and in lymph nodes were deleted almost completely. More-
over, remaining splenic  B cells were arrested in development 
at a transitional stage. At the site of superantigen expression, the 
liver,  B cells were present but had down-regulated sIg and 
expressed a reduced density of CD19, obviously suggesting 
that they had encountered autoantigen. A fraction of  liver   
B cells contained active caspase 3, indicating that they were in 
the process of apoptosis. Although active apoptosis has been 
seen in models of peripheral B cell deletion in response to a 
bolus of tolerogen of exogenous origin (Murakami et al., 
1992; Tsubata et al., 1994; Finkelman et al., 1995; Goodyear 
and Silverman, 2004), the present model is, to our know-
ledge,  the  first  to  demonstrate  ongoing  peripheral  B  cell 
apoptosis in the steady-state.
Liver-expressed superantigen failed to promote significant 
receptor editing. Although in spleen Rag2 gene expression 
was slightly elevated, Rag1 levels were normal. Given the 
enrichment in pAlb spleen of immature B cells, which are 
known to have some residual Rag1 and Rag2 message (Yu   
et al., 1999), the requirement for both Rag-1 and -2 for func-
tional recombinase activity, and the fact that most of the pop-
ulation was effectively autoreactive, the slight difference in Rag2 
mRNA was not consistent with extensive ongoing editing. 
BAFF levels, autoimmune disease, and the abrogation of B cell 
tolerance (Lesley et al., 2004; Thien et al., 2004; Mackay and 
Schneider, 2009; Ota et al., 2010). Accordingly, we bred fe-
male pAlb mice with male pCD68-BAFF transgenics (Gavin 
et al., 2005) and analyzed  cells in these pAlb/BAFF double 
transgenic mice (Fig. 6 A, right).  B cell deletion was im-
paired in seven of eight analyzed pAlb/BAFF mice, as re-
vealed by increased numbers of + B cells in lymph nodes 
(Fig. 6, A–C). However, one pAlb/BAFF mouse had almost 
no + B cells in the lymph nodes, indicating that in this 
mouse, tolerance induction was intact and that BAFF over-
expression failed to promote B cell escape (Fig. 6 B).
Several other parameters indicated that  splenic B cells   
of pAlb/BAFF mice had restored function. Most cells ap-
peared more mature as they had reduced expression of CD93 
(Fig. S2 C). BCR cross-linking induced a more normal Ca2+ 
flux in pAlb/BAFF + splenocytes compared with pAlb   
+ cells (Fig. 6 F), and i staining of splenocytes revealed a 
massively expanded + plasma cell population (Fig. 6 D, com-
pare boxes in the two panels on the right). These B220loihi  
B cells were confirmed to be plasma cells by their CD138hi 
CD19lo cell surface phenotype (Fig. 6 E).
Periportal lymphocytic infiltrates in pAlb and pAlb/BAFF mice
Hematoxylin and eosin (H&E) stain histological examination 
of the liver was performed to assess possible inflammation and 
hepatocyte damage at the site where the tolerogenic ligand 
was expressed. We detected some lymphocyte infiltration in 
the periportal vein areas in pAlb liver and, more frequently, 
in pAlb/BAFF livers (Fig. 7 A). In WT and BAFF mice, no 
infiltrate was observed (Fig. 7 A). We also examined mouse 
liver sections with anti-IgM and anti-IgG1 staining, reveal-
ing Ig deposition in pAlb/BAFF but also in BAFF samples 
Figure 7.  Periportal vein lymphocytic infiltration in pAlb/BAFF double transgenic mice. pAlb, BAFF, pAlb/BAFF, and WT mice were compared for 
inflammation and Ig deposition in liver. (A) Perfused livers were either fixed and analyzed by H&E staining (top) or frozen with Tissue-Tek and stained with 
Alexa Fluor 488–rat anti–mouse IgM or with FITC–rat anti–mouse IgG1. (B) ALT levels in sera of mice of the indicated genotypes. Three mice of each gen-
otype were analyzed in these experiments. Error bars indicate SEM.JEM VOL. 208, March 14, 2011 
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subset of + cells in the peritoneal cavity appeared to be resis-
tant  to  deletion  and  included  both  B-1  and  conventional   
B cells. We suggest that these cells escaped deletion because 
their trafficking history resulted in less frequent exposure to 
the liver, possibly because of preferential trafficking to the gut 
tissues, where the superantigen is not expressed.
The deletion of  B cells was clearly T cell independent. 
Previous studies in the MD4/soluble HEL model suggested 
that cognate helper T cells might be toxic to anergic B cells 
(Rathmell et al., 1995, 1996), whereas a more recent study in 
the same system suggested that bystander T cells promote im-
proved survival of these same anergic cells (Lesley et al., 2006). 
Our results fit better with the latter study, although we have 
not specifically explored the effects of cognate helper T cells.
The  B cells in the spleens of pAlb mice were, like sullen 
teenagers, semi-mature and anergic. Previously described an-
ergic cells are thought to have a short half-life, require con-
tinuous  presence  of  autoantigens  to  maintain  the  tolerant 
state (Goodnow et al., 1991; Fulcher and Basten, 1994; Gauld 
et al., 2005), and are identified as CD23hiIgMloCD93hi T3 
cells (Merrell et al., 2006). In BCR transgenic mice, anergic   
B cells were characterized as having reduced sIgM expression, 
near normal IgD, elevated MHCII expression, and impaired 
Ca responses to BCR ligation (Goodnow et al., 1988; Healy 
et al., 1997; Cornall et al., 1998; Benschop et al., 2001; Seo   
et al., 2003). The  B cells of pAlb spleens had elevated   
MHCII levels, reduced sIg, rapid turnover, and blunted Ca2+ 
responses, but their surface phenotype differed from anergic 
B cells described in other models (Cambier et al., 2007), in that 
they had a T3 phenotype, CD21CD23CD93+IgMloIgDint 
(Kiefer et al., 2008). In addition, we were unable to detect 
an elevated basal level of Ca2+ (Fig. S1 B), which has been de-
scribed in some anergic B cells continually exposed to soluble 
antigen (Healy et al., 1997). Cells with the T3 phenotype 
represent a small subset in WT mice and were defined in 
3H9/V8 and 3H9-56R/V8 anti-DNA site-directed trans-
genic mice, in which they are more numerous (Kiefer et al., 
2008; Ota et al., 2010). The differences in models might be 
the result of differences in the nature of the BCR transgenics 
studied, as B cells had already encountered cognate antigen in 
the BM in those studies and had continuous exposure to 
tolerogen in the spleen.
As  this  study  demonstrates,  superantigens  facilitate  the 
study of lymphocyte responses by allowing the stimulation of 
a significant subset of cells in a polyclonal repertoire. One ad-
vantage of their use over alternative techniques, such as BCR 
transgenic models, is that superantigens do not perturb B cell 
development before their encounter. Custom designed supe-
rantigen transgenes have the additional advantage of facilitat-
ing expression in a controlled and tissue-specific way. Previous 
studies of peripheral B cell tolerance of tissue-restricted mem-
brane self-antigens made use of conventional Ig transgenic 
mice (Russell et al., 1991; Akkaraju et al., 1997), which are 
nonideal systems in terms of permitting efficient receptor ed-
iting. Moreover, they usually skew B cell lineages in favor of 
particular subsets even in the absence of cognate autoantigen 
Analysis of  B cell numbers as a surrogate marker for re-
ceptor editing gave a similar picture: although  cell number 
was slightly increased in the spleens of pAlb and TCR/ 
pAlb mice, no such increase was seen in lymph nodes. We   
ascribe the modest increase in  cells in the spleens not to   
editing but rather to expansion of  MZ B cells to fill that com-
partment. However, it is difficult to completely exclude the pos-
sibility that editing occurs in a small subset of B cells. Nor can 
we formally exclude the possibility that extra BM editing might 
occur in B cells encountering autoantigens in peripheral tissue 
other than liver or because of contact with antigens in special 
forms, although we suspect that this is unlikely. We conclude 
that receptor editing in response to the superantigen was neg-
ligible, instead  B cells predominantly underwent clonal de-
letion, likely preceded by a short-lived anergic phase.
Our data suggest that deletion in pAlb mice might require 
multiple antigenic hits over time. Despite the absence of 
superantigen expression in the spleen, splenic  B cells showed 
signs of antigen experience, including BCR down-modula-
tion, MHCII up-regulation, and BCR desensitization as man-
ifested by reduced BCR-triggered Ca2+ responses. Furthermore, 
among the clearly antigen-experienced, sIg down-modu-
lated B cells of liver, only a small subset expressed caspase 3. 
To explain these features, we imagine that B cells might leave 
the liver after a first pass, returning through the blood to the 
spleen in an anergic state, possibly later reentering the circula-
tion whence they again encounter liver antigens. (Anergic B 
cells are known to have altered migration patterns, including 
improved chemotaxis to CCR7 ligands [Cyster et al., 1994; 
Fulcher et al., 1996; Reif et al., 2002].) Eventually, a certain 
proportion  of    B  cells  undergo  apoptosis. This  scenario 
would explain why the splenic  population is largely made 
up of anergic cells with high MHCII levels and only a small 
subset of liver  B cells were actively apoptotic despite their 
uniformly profound sIg down-regulation. It is likely that most 
B cells encounter liver antigens before their migration to the 
spleen because of the liver’s more significant blood flow and 
volume, including massive inputs from both the hepatic ar-
tery and portal vein. It is unlikely that soluble, shed superanti-
gen is responsible for the effects on splenic  B cells because 
(a) it is present at too low a level to explain these results and 
(b) significant levels should have affected BM development 
and triggered editing. (Using a reagent that sees the rat   
IgG1Fc tag portion of the superantigen, we measured serum 
superantigen at 93 ± 44 ng/ml, but this material lacked de-
tectable Ig binding activity [<1 ng/ml].) In a previous study 
in 3-83 BCR transgenic mice, we found that an anergic phe-
notype was induced when the frequency of cells carrying 
cognate membrane autoantigen was low, but when this fre-
quency was high, it led to deletion and receptor editing (Lang 
and Nemazee, 2000). Because changing the frequency of 
antigen-carrying cells should not greatly affect the strength of 
signal caused by any particular encounter between B cells and 
antigen-carrying cells, we proposed that the frequency of en-
counter of antigen by B cells was important. Also consistent 
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(Duong et al., 2010). In that case, tolerogen was ubiquitously 
expressed and encountered at the T1/T2 transitional stage, 
whereas here the B cells encountering autoantigen were clearly 
more mature and BAFF responsive. However, we cannot yet 
definitively  exclude  the  possibility  that  in  the  pAlb/BAFF 
mice the frequency of competing, nonautoreactive B cells was 
too low compared with the IgD-macroself model to allow 
normal competition-dependent homeostasis. In pAlb/BAFF 
double transgenic mice, direct immunofluorescence analysis 
revealed binding of IgM and IgG1 to hepatocytes. However, 
similar binding was seen even in the absence of superantigen 
in BAFF singly transgenic mice. Although other BAFF trans-
genic models have been seen to have immune complexes and 
Ig deposition in kidney (Mackay et al., 1999), to our knowl-
edge, the liver has not been described as an autoantibody tar-
get. A key difference between pAlb/BAFF and BAFF mice 
was the lymphocyte infiltrations observed in the periportal 
vein area of the former mice, which bear some similarities to 
autoimmune hepatitis. Ig deposition was observed, but serum 
ALT levels were not elevated, and histological analysis of H&E-
stained sections revealed no obvious cell necrosis. Presumably, 
hepatocytes are able to limit further inflammation caused by Ig 
deposition. Autoimmune hepatitis is characterized by auto-
antibodies to nuclear antigens, smooth muscle, and liver/kidney 
microsomes and is accompanied by chronic inflammatory cell 
infiltration to the liver. Therefore, BAFF transgenic mice may 
be a good model for the predisease stage of this disease, whereas 
the pAlb/BAFF double transgenic mice could be an interest-
ing model for the more advanced disease stage.
The liver may be an especially efficient organ for the in-
duction of B cell tolerance because of its size and accessibility 
to B cells in the blood. The slow blood flow and fenestrated 
hepatic endothelia directly expose blood-borne cells to the 
surfaces of hepatocytes, and the liver is known to be particu-
larly  tolerogenic  to T  cells  (Thomson  and  Knolle,  2010). 
Moreover, this tissue is usually quite resilient, with the ability 
to regenerate after damage. As this study shows, the liver ap-
pears to be quite resistant to the negative effects of autoanti-
bodies. The liver is also a significant potential host cell target 
of gene therapies. Adenovirus vectors and even naked plasmid 
DNA can be taken up and expressed by hepatocytes (Liu   
et al., 1999; Zhang et al., 1999; Ota et al., 2009; Somanathan 
et al., 2010). Our study suggests that expression of autoanti-
gens or macroself antigens of interest in the liver might be an 
interesting way to treat diseases caused by tissue-specific auto-
reactive B cells and their antibodies.
MATERIALS AND METHODS
Mice. 8–12 wk-old mice were used in most experiments. C57BL/6J mice 
were purchased from the Scripps Research Institute breeding colony. pAlb 
mice were generated on the C57BL/6J background (see next section). All other 
transgenic and mutant strains used were backcrossed at least 10 generations 
onto C57BL/6J. BAFF transgenic mouse line MB21 (Gavin et al., 2005)   
was bred and maintained in the Scripps Research Institute Animal Re-
sources facility according to The Scripps Research Institute Institutional 
Animal Care and Use Committee guidelines.  TCR-// mice (B6.129P2-
Tcrbtm1Mom Tcrdtm1Mom/J) were obtained from the Jackson Laboratory.
and often lead to premature BCR expression and accelerated 
B cell development. In pAlb mice, liver tissue antigens, rather 
than B cells, were modified, which should have permitted 
normal B cell development up to the point that B cells en-
countered the superantigen, including providing Ig genes in   
a normal genomic context that should facilitate receptor edit-
ing. In any case, the fact that the B cell tolerance phenotype 
of the pAlb mice was very similar to previously investigated 
3-83/liver-Kb models (Russell et al., 1991; Kouskoff et al., 
2000) suggests that there was no fundamental difference be-
tween  superantigen and native self-antigen (Kb) in the abil-
ity to promote tolerance.
Using targeted Ig genes that changed BCR specificity 
upon  interferon-induced  cre/lox-mediated  inversion,  Lam 
and Rajewsky (1998) assessed the fate of mature B cells that 
acquired the 3-83 receptor on a Kb background. Consistent 
with our findings, these authors concluded that the autoreac-
tive B cells underwent deletion. Similar results were obtained 
in a model in which B cells in normal adult mice were chal-
lenged by transfusion with cells carrying an IgD-macroself 
antigen (Duong et al., 2010). These studies were potentially 
capable of detecting elevated editing in mature peripheral   
B cells but failed to do so.
Maternal IgGs affected tolerance of  B cells in pAlb 
mice, presumably by masking liver-expressed superantigen. 
As a consequence, in the offspring of WT females,  B cells ap-
peared to significantly escape deletion and to populate lymph 
nodes, an effect which was retained long after weaning and 
thus was likely perpetuated by host  Ig and/or  B cell pro-
duction (Fig. S2, A and B). However, the effect was incom-
plete. Compared with WT, these mice had a lower frequency 
of  B cells and a higher frequency of  cells. In contrast, off-
spring of female pAlb mice were fully tolerant, with minimal 
escape from deletion and little or no serum Ig. In any case, 
these findings support the suggestion (Wang and Shlomchik, 
1998) that maternal IgG autoantibodies might imprint offspring 
in a way that similarly diminishes B cell tolerance to their tar-
gets and ultimately increases the risk of autoimmunity.
The phenotype of  B cells in the peritoneal cavity of 
pAlb mice defied our predictions in that they included not 
only B1 cells but also B2 cells. B1 cells are well known to be 
enriched in cells with weak self-reactivity, likely owing to active 
positive selection by self-ligands and a resistance to apoptosis 
(Hayakawa et al., 1999; Otero et al., 2006). However, in pAlb 
mice, we saw a reduced frequency of  B cells with little 
change in the B1/B2 ratio. The surface phenotype of these 
remaining  cells was not indicative of antigen encounter.   
As the  superantigen, when accessible, engages the BCRs of 
these cells similarly, we conclude that the cells probably escaped 
by clonal ignorance owing to their distinct migratory proper-
ties rather than any intrinsic BCR signaling differences.
We  found  that  in  pAlb  mice,  the  overexpression  of 
BAFF could rescue  B cells from anergy and deletion and 
promote their differentiation to plasma cells. It is interesting 
to compare this result with the inability of the same BAFF 
transgene to overcome tolerance to an IgD-macroself antigen   JEM VOL. 208, March 14, 2011 
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1 h with mouse sera diluted in ELISA buffer. Purified IgG1  (MG1-45; Bio-
Legend) was used as a standard. Horseradish peroxidase–conjugated anti- 
(187.1; BD) diluted in ELISA buffer was used to report signals using 1-Step 
Ultra-TMB substrate (Thermo Fisher Scientific) per the manufacturer’s in-
structions. Signals were recorded at 450 nm using a microplate reader (Versa-
Max; MDS Analytical Technologies).
Isolation of liver lymphocytes. Isolation of intrahepatic lymphocytes was 
performed as previously described (Isogawa et al., 2005). In brief, livers were 
perfused with 10 ml of FACS buffer via the portal vein to remove circulating 
lymphocytes, and the liver cell suspension was pressed through a 70-µm cell 
strainer and digested with 10 ml of RPMI 1640 medium (Invitrogen), con-
taining 0.02% (wt/vol) collagenase IV (Sigma-Aldrich) and 0.002% (wt/vol) 
DNase I (Sigma-Aldrich), for 40 min at 37°C. Cells were washed with FACS 
buffer and then overlaid on Lympholyte-M (Cedarlane). After centrifugation 
for 20 min at 1,500 g, the intrahepatic lymphocytes were isolated at the in-
terface, washed twice with FACS buffer, and used for further analysis.
Histology. Perfused liver was fixed (Z-FIX; Anatech), and H&E sections 
were processed at the Scripps Research Institute Histology Core. Direct im-
munofluorescence was performed to examine the in vivo deposition of IgG/
M on the hepatocytes. The perfused livers were embedded in OCT com-
pound (Sakura). Each sample was incubated with a 100-fold dilution of Alexa 
Fluor 488–anti-IgM (M41), FITC IgG1 (A85-1; BD), or FITC rat–IgG1 
(RG11/39.4; BD). The specimens were examined using a fluorescence mi-
croscope (Eclipse E8000; Nikon).
Online supplemental material. Fig. S1 shows analysis of Ca2+ mobiliza-
tion and BrdU uptake in + B cells of pAlb spleen, documenting their hypo-
responsiveness and rapid turnover. Fig. S2 shows reanalysis of leaky mice at   
5 mo of age, documenting the stability of their phenotype after maternal an-
tibody should be absent. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20102265/DC1.
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Transgenic  mouse  generation.  The  albumin  enhancer  and    fe-
toprotein  enhancer  II  region  were  amplified  from  B6  genomic  DNA 
using  primer  pairs  A62  AlbF  (5-AAGGAGGATCCTTAATTAACTA-
GCTTCCTTAGCATGACGTTCCA-3) and A63 AlbR (5-TTTCG-
GACTAGTCAAGCTGGAGAACGAGTTCAAGC-3)  and  A64  AfpF 
(5-AAGGGACTCGAGCCTGAAAGAGTGAAAGTCATTTTCTGC-3) 
and  A65  AFpR  (5-TTTCTTGGCATATGTTAATTAAATCCCATA-
ATCAGCTTCCAAACGCTG-3), respectively. All cloned products were 
confirmed by sequencing. The albumin fragment was digested with BamH1 
and SpeI and cloned into BglII–BamH1-digested pLive plasmid (Mirus Bio 
LLC). Subsequently, the  fetoprotein fragment was digested with XhoI and 
NdeI and cloned into XhoI–NdeI-digested plasmid carrying the albumin 
enhancer. SalI–SacI-digested  superantigen fragment including the poly A 
site was then introduced to this vector to yield pLive3-187.1. This plasmid 
was digested with PacI and used to generate pAlb mice by microinjection 
of B6 zygotes. 24 founders were obtained. Data presented here were from a 
single representative line.
Flow cytometry analyses. Flow cytometric analyses for surface markers 
were performed using standard protocols as previously described (Duong   
et al., 2010). To visualize intracellular proteins, cells were first permeabilized 
using the Cytofix/Cytoperm kit (BD) according to manufacturer’s recom-
mendations. The following mAbs were used at 1:200 in all experiments de-
scribed:  B220  (RA3-6B2;  FITC;  BioLegend),  CD19  (1D3;  PE/Cy7; 
eBioscience), CD21 (7E9; FITC; eBioscience), CD23 (B3B4; PE; eBiosci-
ence), CD86 (GL1; PE; BD), CD93 (AA4.1; PE or allophycocyanin; eBiosci-
ence), IgD (11-26; PE; eBioscience), Ig (187.1; FITC or Pacific blue; BD), 
and Ig (RLM-42; APC; BioLegend). mAbs against mouse IgM (M41; Alexa 
Fluor 488) and B220 (Pacific blue) were labeled in-house. To gate out most 
T cells, in some analyses we included a dump antibody mixture consisting   
of PerCP/Cy5.5-labeled mAbs against CD4 (RM4-5; BioLegend) and CD8 
(53-6.7; BioLegend). All samples were read on an LSR-II instrument (BD) 
and analyzed using the FlowJo program (Tree Star, Inc.).
Ca2+ flux assays. Total spleen cells isolated from pAlb mice and their non-
transgenic littermates were pooled and resuspended at 2 × 107 cells/ml in 
RPMI. A total of 107 spleen cells was then preincubated with 1.5 µM Indo-1 
(Invitrogen), 5 µg Fc Block (2.4G2; BD), and 1 µg each of PerCP/Cy5.5- 
labeled CD4, CD8, and APC–anti- for 30 min at 37°C, followed by another 
30 min at room temperature. Aliquots of 4 × 106 cells (0.5 ml) were then 
stimulated at room temperature with 2 or 10 µg/ml anti–mouse IgM (M41) 
or anti–mouse  (187.1) in IgG form. Ca2+ signals were recorded for 200 s, 
gating on CD4/CD8/Gr-1/-negative cells and measuring the 405/485-nm 
emission ratio of Indo-1 fluorescence upon UV excitation.
Quantitative RT-PCR. + and B220+ B cells were purified from spleen or 
BM using biotinylated anti- plus antibiotin microbeads or with B220 
microbeads (Miltenyi Biotec), respectively, and their total RNA was isolated   
using RNeasy Plus (QIAGEN) per kit instructions. RT was performed with 
a QuantiTect RT kit (QIAGEN) per the manufacturer’s protocol. PCR reac-
tions were performed using GoTaq quantitative PCR (Promega) and analyzed 
on the 7900HT Fast Real-Time PCR system (Applied Biosystems). Annealing 
temperature per cycle was set to 60°C. Quantifications of RAG1 and RAG2 
mRNA were normalized with concomitant amplifications of -actin message 
in each triplicate sample. The following primers were used: RAG1 F, 5-GGAG-
GCCTGTGGAGCAAGGTAG-3; RAG1 R, 5-GTTCTGACCACCAG-
GCTTCTCT-3; RAG2 F, 5-CCCAGTGCATGGATTTGGAAGAAC-3; 
RAG2 R, 5-GGAGTTTGCAATGCTCTTGCTATCTG-3; -actin F,   
5-CAACCGTGAAAAGATGACCCAGA-3; and -actin R, 5-CACAG-
CCTGGATGGCTACGTAC-3.
Serum ELISA. Maxisorp plates (Thermo Fisher Scientific) were coated 
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